When it comes to cancer treatment and outcomes, every day seems to bring new innovations and improvements. But according to a recently published study from a respected research cooperative of Spanish oncologists, patients diagnosed with malignant pleural mesothelioma continue to face steep challenges and grim overall survival times.
When mesothelioma and asbestos lung cancer victims file lawsuits against those responsible for their illness, their attorneys warn them to expect the worst from the asbestos companies and those companies’ attorneys. Just as the companies put profits over people when they exposed workers to asbestos-contaminated products, they will say and do almost anything to avoid
When researchers at the 2019 World Conference on Lung Cancer announced they’d seen positive results from a new early lung cancer detection tool, it raised the hopes of mesothelioma physicians around the world. The rare and fatal form of lung cancer caused by exposure to asbestos is notoriously difficult to treat, and one of the
The scientific community has determined that exposure to asbestos dramatically increases the risk that cigarette smokers will be diagnosed with malignant mesothelioma, and the same is true of lung cancer. Yet despite incontrovertible evidence in support of this connection, Consolidated Rail Corporation (Conrail) argued in court against its responsibility for a longtime railroad worker’s diagnosis
When people are first diagnosed with malignant mesothelioma or other asbestos-related diseases, they’re often shocked to learn that they were exposed to asbestos by iconic companies like Ford Motor Company. That is exactly what happened to John Decastro, who was diagnosed with lung cancer after years of having maintained his Ford vehicles, whose parts were
One of the first things that a mesothelioma victim is told after their diagnosis is that the disease has a very short life expectancy. Some are told to get their affairs in order, while others may have a prognosis that promises a year, perhaps two. The medical community has been striving to find better treatment
Keytruda (pembrolizumab) is an immunotherapy drug for cancer treatment originally approved for patients with specific genetic markers. Continuing studies led to Keytruda being approved for advanced pleural mesothelioma and some types of asbestos lung cancer. Facts About Keytruda Is Pembrolizumab Approved for Mesothelioma? Unlike other cancer drugs, Keytruda’s FDA approval is based not only on
Lung cancer is the second most common type of cancer and the leading cause of cancer death in the U.S., and some cases are triggered by asbestos exposure. The prognosis for asbestos lung cancer is poor. Early diagnosis and treatment can increase life expectancy. What Is Asbestos Lung Cancer? Asbestos-related lung cancer is a cancer
Mesothelioma is not a type of lung cancer. They are two different types of cancer that are diagnosed and treated very differently, but because mesothelioma is rare, it is often misdiagnosed as lung cancer. Getting a thorough diagnosis for symptoms, including second or third opinions, is essential. Mesothelioma vs. Lung Cancer Mesothelioma and lung cancer
Malignant pleural mesothelioma is a notoriously difficult form of cancer to treat. The aggressive, asbestos-related disease is always considered fatal, with most patients succumbing to their illness within a year of diagnosis. However, the Froedtert & the Medical College of Wisconsin health network recently reported good results after treating a patient with immunotherapy drugs.